Bihua Chen
Director/Board Member at BIOMEA FUSION, INC.
Net worth: - $ as of 2024-05-30
Profile
Bihua Chen is the founder and the Chief Executive Officer & Portfolio Manager of Cormorant Asset Management LP, which was founded in 2013.
Ms. Chen is also the founder of Cormorant Asset Management LLC.
Ms. Chen's current job positions include Director at Atia Vision, Inc., Independent Director at Biomea Fusion, Inc., Director at Blossomhill Therapeutics, Inc., Director at Chroma Medicine, Inc., Director at Orionis Biosciences BV, Managing Member at C4 Therapeutics, Inc., Managing Member at CRMA SPV LP, Managing Member at Cormorant Private Healthcare Fund I LP, Managing Member at Cormorant Private Healthcare Fund II LP, and Manager at Helix Holdings LLC.
Ms. Chen's former job positions include Chairman & Chief Executive Officer at Helix Acquisition Corp.
and Helix Acquisition Corp.
II, Independent Director at Apellis Pharmaceuticals, Inc., Director at Atea Pharmaceuticals, Inc., Director at Turning Point Therapeutics, Inc., Managing Director at North Tide Capital LLC, Independent Director at Erasca, Inc., Senior Analyst at RiverSource Investments LLC, Principal at BB Biotech AG, Principal at American Express Asset Management International (UK), Equity Analyst at Putnam U.S.
Holdings I LLC, Portfolio Manager at Millennium Management LLC, Portfolio Manager at Bellevue Research, Inc., Portfolio Manager at American Express Asset Management Group Inc., Principal at Asterion LLC, and Venture Partner at Impresa Management LLC.
Ms. Chen's education includes an undergraduate degree from Fudan University in 1990, a graduate degree from Weill Cornell Medical College in 1994, and an MBA from The Wharton School of the University of Pennsylvania in 1998.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
BIOMEA FUSION INC
-.--% | 2024-03-30 | 0 ( -.--% ) | - $ | 2024-05-30 |
Bihua Chen active positions
Companies | Position | Start |
---|---|---|
C4 THERAPEUTICS, INC. | Corporate Officer/Principal | - |
BIOMEA FUSION, INC. | Director/Board Member | 2020-11-30 |
Orionis Biosciences BV
Orionis Biosciences BV Pharmaceuticals: MajorHealth Technology Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015. | Director/Board Member | 2021-06-28 |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Director/Board Member | - |
Helix Holdings LLC | Corporate Officer/Principal | - |
CRMA SPV LP | Corporate Officer/Principal | - |
Cormorant Private Healthcare Fund II LP | Corporate Officer/Principal | - |
Cormorant Private Healthcare Fund I LP | Corporate Officer/Principal | - |
Atia Vision, Inc.
Atia Vision, Inc. Electronic Equipment/InstrumentsElectronic Technology Atia Vision, Inc. provides medical device services. The company was founded in 2012 and is headquartered in Campbell, CA. | Director/Board Member | - |
░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Former positions of Bihua Chen
Companies | Position | End |
---|---|---|
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Bihua Chen
Fudan University | Undergraduate Degree |
Weill Cornell Medical College | Graduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 7 |
---|---|
BB BIOTECH AG | Finance |
APELLIS PHARMACEUTICALS, INC. | Health Technology |
ATEA PHARMACEUTICALS, INC. | Health Technology |
KEZAR LIFE SCIENCES, INC. | Health Technology |
C4 THERAPEUTICS, INC. | Health Technology |
ERASCA, INC. | Health Technology |
BIOMEA FUSION, INC. | Health Technology |
Private companies | 21 |
---|---|
RiverSource Investments LLC
RiverSource Investments LLC Investment ManagersFinance RiverSource Investments LLC, formerly American Express Financial Corp., is a registered investment advisor and mutual fund manager headquartered in Minneapolis, Minnesota with offices in New York City, Maryland, Massachusetts and California. The firm is a wholly-owned subsidiary of Ameriprise Financial Services, Inc. (NYSE: AMP). RiverSource Investments provides investment management services to the RiverSource Investments family of funds (formerly the American Express Funds). The firm also provides investment management services for institutional clients, alternative investments, insurance assets and a managed account program. | Finance |
American Express Asset Management International (UK)
American Express Asset Management International (UK) Financial ConglomeratesFinance American Express Asset Management International (UK) is a global payments, network and travel firm which is headquartered in London, UK. | Finance |
Putnam U.S. Holdings I LLC
Putnam U.S. Holdings I LLC Investment ManagersFinance Putnam Investments LLC operates as an investment advisory company. The company was founded on May 14, 2009 and is headquartered in Boston, MA. | Finance |
Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
Millennium Management LLC
Millennium Management LLC Investment ManagersFinance Millennium Management LLC is a SEC-investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Israel 'Izzy' Englander in 1989 and is a subsidiary of MLM Trust B LLC, itself a subsidiary of MLM Trust B. Millennium Management provides discretionary investment advisory services to private investment funds. | Finance |
Bellevue Research, Inc.
Bellevue Research, Inc. Investment ManagersFinance Founded in 1998, Bellevue Research, Inc. is a fundamental equity investment research firm located in Boston. The firm is US investment research arm of Bellevue Asset Management AG, a privately-owned asset management group based in Zurich, Switzerland. Their ultimate parent is Bellevue Group AG. Bellevue research provides research to Bellevue Asset Management with coverage of the biotechnology, genetic engineering and pharmaceuticals sectors. | Finance |
North Tide Capital LLC
North Tide Capital LLC Investment ManagersFinance North Tide Capital LLC is an independent hedge fund management firm headquartered in Boston, Massachusetts. The firm was founded by Conan Laughlin in 2010 as BCL Capital Management. North Tide Capital provides discretionary investment advisory services to institutional investors and other sophisticated investors. | Finance |
American Express Asset Management Group Inc. | |
Asterion LLC
Asterion LLC Chemicals: SpecialtyProcess Industries Asterion LLC manufactures chemical finishing products. The company was founded in January and is headquartered in Indianapolis, IN. | Process Industries |
Cormorant Asset Management LP
Cormorant Asset Management LP Investment ManagersFinance Cormorant Asset Management LLC (Cormorant) is an independent hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Bi Hua Chen in 2013. Cormorant provides discretionary investment advisory services to hedge funds, private equity funds and separately managed accounts. Investors in the Funds consist of institutional investors and other sophisticated investors. | Finance |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Finance |
Atia Vision, Inc.
Atia Vision, Inc. Electronic Equipment/InstrumentsElectronic Technology Atia Vision, Inc. provides medical device services. The company was founded in 2012 and is headquartered in Campbell, CA. | Electronic Technology |
CRMA SPV LP | Finance |
Cormorant Asset Management LLC/Private Equity/
Cormorant Asset Management LLC/Private Equity/ Investment ManagersFinance Cormorant Asset Management LLC/Private Equity/ (Cormorant Asset Management) is a venture capital subsidiary of Cormorant Asset Management LP founded in 2013 by Bi Hua Chen. The firm is headquartered in Boston, Massachusetts. | Finance |
Cormorant Private Healthcare Fund I LP | Finance |
Cormorant Private Healthcare Fund II LP | Finance |
Helix Acquisition Corp.
Helix Acquisition Corp. Financial ConglomeratesFinance Helix Acquisition Corp. operates as a blank check company. It is a special purpose acquisition company which is incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 13, 2020 and is headquartered in Boston, MA. | Finance |
Helix Holdings LLC | |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | Health Technology |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Health Technology |
Orionis Biosciences BV
Orionis Biosciences BV Pharmaceuticals: MajorHealth Technology Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015. | Health Technology |
- Stock Market
- Insiders
- Bihua Chen